PC
PHGE icon

Periscope Capital’s BiomX PHGE Stock Holding History

Periscope Capital’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,382
Closed -$2.67M – 244
2019
Q3 		$2.67M Buy
1,382
+556
+67% +$1.09M 0.35% 106
2019
Q2 		$1.54M Buy
+826
New +$1.53M 0.22% 118

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Periscope Capital's PHGE Position: Q4 2019 in Review

Periscope Capital sold out of BiomX (PHGE) in Q4 2019, closing a stake of 1,382 shares — an estimated $2.67M sold.

Periscope Capital first reported a position in PHGE in Q2 2019 and held it in 2 quarters. The position peaked at $2.67M in Q3 2019. 7 funds tracked by Wall St. Rank hold PHGE as of Q4 2019.

  • Periscope Capital reported no remaining BiomX position as of Q4 2019 after selling out during the quarter.
  • Periscope Capital sold 1,382 BiomX shares in Q4 2019, an estimated $2.67M.
  • Periscope Capital first reported a position in BiomX in Q2 2019 and held it in 2 quarters.
  • Periscope Capital's BiomX position peaked at $2.67M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held BiomX as of Q4 2019.

Based on Periscope Capital's 13F filing for Q4 2019, filed 5 Feb 2020.